Skip to content

Clinical study of Ardrak swaras in Urticaria

Open randomized controlled clinical trials Of efficacy Of addrak swaras zingiber officinale In the management Of sheetpitta with special refference to urticaria - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057528
Enrollment
80
Registered
2023-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L502- Urticaria due to cold and heat

Interventions

None listed

Sponsors

Dr Chandrakant Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient with sign and symptoms of Sheetpitta Mandal Kandu Toda Daha Jwar Chardi are included in study 2 Patient age group between 20 to 60 yrs 3 Patients selected irrespective of age Sex socio economic status

Exclusion criteria

Exclusion criteria: 1 Pregnancy and Lactating Mother 2 History of Allergic to Medicine 3 Patient with other co morbidities like Diabetes Mellitus HIV Psoariasis Eczema etc

Design outcomes

Primary

MeasureTime frame
Ardrak swaras is effective in the management of SheetpittaTimepoint: 4 weeks

Secondary

MeasureTime frame
Amruta kwath is effective in the management of SheetpittaTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Parag Deshmukhe

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026